This small bill's saga highlights a tough road for bigger drug pricing reforms

This small bill's saga highlights a tough road for bigger drug pricing reforms

Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms

By NICHOLAS FLORKO

DOM SMITH/STAT

The decadelong struggle of the CREATES Act shows that passing drug pricing bills is comically difficult in Washington — even when the bill is bipartisan.

READ MORE